Value of periodic transcutaneous daytime Carbon dioxide monitoring in screening for Respiratory failure in patients with Amyotrophic lateral sclerosis

Authors

Muhammad K Rafiq, Norfolk and Norwich University Hospital NHS Trust

Document Type

Original Article

Abstract

There is no single test currently available, which can predict respiratory failure in patients with amyotrophic lateral sclerosis (ALS) with high sensitivity and specificity. This study explores the potential use of transcutaneous carbon dioxide (PtcCO2) monitoring in early detection of respiratory failure in ALS.

Recommended Citation

Rafiq, Muhammad K (2019) "Value of periodic transcutaneous daytime Carbon dioxide monitoring in screening for Respiratory failure in patients with Amyotrophic lateral sclerosis," Pakistan Journal of Neurological Sciences (PJNS): Vol. 14: Iss. 1, Article 7.
Available at: https://ecommons.aku.edu/pjns/vol14/iss1/7